MeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. MeiraGTx have six programs in clinical development including four ocular indications, a salivary gland condition, and a Parkinson’s disease program.
Greg SimmondsDirector of Site Operations
Areas of Expertise
- Gene therapy (viral)
- Manufacturing sciences
- Process Development